Latest News

Latest News2018-07-31T19:14:53+01:00

CroíValve wins FDA IDE for tricuspid heart valve

February 7th, 2024|

CroíValve announced today that it began an early feasibility study for its Duo tricuspid coaptation valve system. The beginning of the study follows FDA investigational device (IDE) approval. Read Full Article

Galway-based medtech FeelTect to expand following €1.5m funding raise

February 6th, 2024|

The Spiddal company is to recruit six staff across research and development, manufacturing, project management, clinical affairs, and commercial strategy. The majority of the new roles will be based in Ireland, with commercial and clinical roles spread across the United States and Europe to support international growth. Read Full Article

Deciphex Secures €10m Venture Debt Financing

October 16th, 2023|

Deciphex, a trailblazer in digital pathology solutions, is delighted to announce a successful €10m venture debt financing round. This strategic investment will fuel the company's capacity growth, headcount increase, service enhancement, and expansion to new markets, addressing the growing global demand in pathology services. Read Full Article

Cinclus Pharma’s phase II eGERD study in two presentations at UEG

October 16th, 2023|

Cinclus Pharma Holding AB (publ) ("Cinclus Pharma"), a pharma company focused on the development of a novel treatment for gastroesophageal reflux disease ("GERD"), today announces that two abstracts from the company's phase II study, LEED, on its leading drug candidate linaprazan glurate, developed for the treatment of moderate to severe erosive GERD ("eGERD"), are being presented at the leading gastro conference United European Gastroenterology ("UEG") which is held in [...]

Sigrid Therapeutics starts clinical trial for diabetes and weight control device

October 16th, 2023|

Sigrid Therapeutics has started the Shine clinical trial for SiPore21, a device designed to control diabetes and obesity. SiPore technology is based on mesoporous silica particles (MSPs), a colloidal amorphous silicon dioxide matrix. It acts like a “molecular sieve” to physically prevent the interaction between digestive enzymes and food, thereby reducing food breakdown into basic absorbable units. The SiPore21 device, if cleared, will be registered as a Class IIb medical device. [...]

VHI and AllView Healthcare launch new dermatology service

October 10th, 2023|

Company will also create 25 jobs this year Health insurer VHI has launched a new telehealth dermatology service in partnership with AllView Healthcare, (formerly DermView) saying it will provide rapid access to care and treatment for skin conditions including acne, lesions and melanomas Read Full Article in the Irish Times

If you are interested in becoming an Investor or seeking investment, then please contact us.

Go to Top